The dopamine antagonist Sch 23390 reverses dizocilpine-induced blockade of cocaine sensitization

Neuropharmacology

Volumn 39, Issue 9, 2000, Pages 1645-1652

  Parada, António ^a   Soares Da Silva, P ^a  

^a DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

Author keywords

Cocaine sensitization; D1 receptors; Dizocilpine; Rat

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DIZOCILPINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; COCAINE; DIZOCILPINE MALEATE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1;

EID: 0034105115     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00238-5     Document Type: Article

References (48)

1. Ackerman J.M., White F.J. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neuroscience Letters. 117:1990;181-187.
2. Bradberry C.W., Roth R.H. Cocaine increase extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neuroscience Letters. 103:1989;97-102.
3. Cervo L., Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats. Brain Research. 731:1996;31-38.
4. 5H ]-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties Drug Development Research. 2:1982;134-145.
5. Dall'Olio R., Gandolfi O., Montanaro N. Effect of treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat. Psychopharmacology (Berlin). 98:1992;342-346.
6. Freeman A.S., Bunney B.S. The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. European Journal of Pharmacology. 104:1984;287-293.
7. French E.D. Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat. Neuropharmacology. 25:1986;241-248.
8. French E.D. Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. Neurotoxicology and Teratology. 16:1994;355-362.
9. French E.D., Cecci A. Nomcompetitive N-methyl-D-aspartate antagonists are potent activators of ventral A10 dopamine neurons. Neuroscience Letters. 119:1990;159-162.
10. French E.D., Ferkany J., Abreu M., Levenson S. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine. Neuropharmacology. 30:1991;1039-1046.
11. French E.D., Mura A., Wang T. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists. Synapse. 13:1993;108-116.
12. Gandolfi O., Rimondini R., Dall'Olio R. The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms. Neuropharmacology. 31:1992;1111-1114.
13. Henry D.J., White F.J. Repeated cocaine administration causes persistant enhancement of D1 dopamine receptor sensitization within the rat nucleus accumbens. The Journal of Pharmacology and Experimental Theraputics. 258:1991;882-890.
14. Henry D.J., Greene M.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. The Journal of Pharmacology and Experimental Theraputics. 251:1989;833-839.
15. Higashi H., Inanaga K., Nishi S., Uchimura N. Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pre-treatment. Journal of Physiology. 408:1989;587-603.
16. Itzhak Y. Attenuation of cocaine kindling by 7-nitroindazole, an inhibitor of brain nitric oxide synthase. Neuropharmacology. 35:1996;1065-1073.
17. Kalivas P.W., Alesdatter J.E. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. The Journal of Pharmacology and Experimental Theraputics. 267:1993;486-495.
18. Kalivas P.W., Duffy P. Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. Journal of Neurochemistry. 70:1998;1497-1502.
19. Kalivas P.W., Duffy P., Eberhardt H. Modulation of A10 dopamine neurons by aminobutyric acid agonists. The Journal of Pharmacology and Experimental Theraputics. 253:1990;858-866.
20. Kamata K., Rebec G.V. Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area. Life Science. 34:1984;2419-2427.
21. Karler R., Calder L.D., Chaudry I.A., Turkanis S.A. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Science. 45:1989;599-606.
22. Karreman M., Westerink B.H., Moghaddam B. Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum. Journal of Neurochemistry. 67:1996;601-607.
23. Kobayashi K., Inoue O. An increase in the in vivo binding of [3H]-SCH23390 induced by MK-801 in the mouse striatum. Neuropharmacology. 32:1993;341-348.
24. Kuribara H., Uchihashi Y. Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice. Journal of Pharmacy and Pharmacology. 45:1993;1042-1045.
25. 2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice. Behavioural Brain Research. 70:1995;145-151.
26. Mattingly B.A., Rowlett J.K., Ellison T., Rase K. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments. Pharmacology Biochemistry and Behaviour. 53:1996;481-486.
27. Murase S., Mathe J.M., Grenhoff J., Svensson T.H. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. Journal of Neural Transmission. 91:1993;13-25.
28. Narayanan S., Willins D., Dalia A., Wallace L., Uretsky N. Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens. Pharmacology Biochemistry and Behaviour. 54:1996;565-573.
29. Ouagazaal A.-M., Nieoullon A., Amalric M. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. European Journal of Pharmacology. 251:1994;229-236.
30. Pudiak C.M., Bozarth M.A. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Science. 53:1993;1517-1524.
31. Rao T.S., Kim H.S., Lehmann J., Martin L.L., Wood P.L. Interactions of phencyclidine receptor agonist MK-801 with the dopaminergic system; regional studies in the rat. Journal of Neurochemistry. 54:1990;1157-1162.
32. Schenk S., Valadez A., McNamara C., House D.T., Higley D., Bankson M.G., Gibbs S., Horger B.A. Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. Psychopharmacology. 111:1993;332-338.
33. Seutin V., Johnson S.W., North R.A. Effect of dopamine and baclofen on N-methyl-D-aspartate-induced burst firing in rat ventral tegmental neurons. Neuroscience. 58:1994;201-206.
34. Starr M.S., Starr B.S. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice. Psychopharmacology (Berlin). 114:1994;469-476.
35. Stweart J., Druhan J.P. Development of both conditioning and sensitization to the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology. 110:1993;125-132.
36. Tricklebank M.D., Singh L., Oles R.J., Preston C., Iversen S.D. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. European Journal of Pharmacology. 167:1989;127-135.
37. Tzschentke T.M., Schmidt W.J. Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration? [see comments]. Trends in Pharmacological Sciences. 19:1998;447-451.
38. Wang T., French E.D. Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: an extracellular in vitro study. Life Science. 53:1993;49-56.
39. Wang T., O'Connor W.T., Ungerstedt U., French E.D. N-methyl-D-aspartic acid biphasically regulates the biochemical and electrophysiological response of A10 dopamine neurons in the ventral tegmental area: in vivo microdyalisis and in vitro electrophysiological studies. Brain Research. 666:1994;255-262.
40. Westerink B.H., Kwint H.F., deVries J.B. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. Journal of Neuroscience. 16:1996;2605-2611.
41. White F.J., Wang R.Y. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment. Brain Research. 309:1984;283-292.
42. White F.J., Joshi A., Koeltzow T.E., Hu X.T. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology. 18:1998;26-40.
43. Willins D.L., Narayanan S., Wallace L.J., Uretsky N.J. The role of dopamine and AMPA/kaynate receptors in the nucleus accumbens in the hypermotility response to MK-801. Pharmacology Biochemistry and Behaviour. 46:1993;881-887.
44. Wolf M.E., Jeziorski M. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Research. 613:1993;291-294.
45. Wolf M.E., White F.J., Nassar R., Brooderson R.J., Khansa M.R. Differential development of autoreceptor sensitivity and enhanced dopamine release during amphetamine sensitization. The Journal of Pharmacology and Experimental Theraputics. 264:1993;249-255.
46. Wolf M.E., White F.J., Hu X.-T. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioural sensitization to amphetamine. Journal of Neuroscience. 14:1994;1735-1745.
47. Wolf M.E., Xue C.-J., White F.J., Dahlin S.L. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Research. 666:1994;223-231.
48. Zhang J., Chiodo L.A. Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Research. 590:1992;153-163.